GLP-1 Drugs Linked to 35% Lower Risk of Breast Cancer Women taking GLP-1 drugs, including Ozempic, Wegovy, and Mounjaro, were around 30% less likely to develop breast cancer than peers not taking the drug
You may have heard that Zepbound is the latest powerhouse in the metabolic health world, but you might also be curious about compounded tirzepatide
The LC flow was set at 0.2 ml min 1 , and the gradient was as follows: 10% A held for 2 min, 35% A at 18 min, 70% A at 22 min, 90% A at 22.1 min and held for 2.9 min, 10 % A at 25.1 min and held for 5 min
In the ACHIEVE-2 trial (Phase 3, 962 adults with type 2 diabetes on metformin), Orforglipron, a novel small-molecule oral GLP-1 RA went head-to-head against Dapagliflozin, one of the most widely used SGLT2 inhibitors
Ipamorelin This peptide mimics the activity of the ghrelin hormone, secreted by the stomach, to trigger the pituitary gland to secrete the growth hormone
Immunohistochemical kits were obtained from Boster Biological Technology Co., Ltd